Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4300-4304
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Table 3 Chemotherapeutic side effects of gastrointestinal cancers (n)
| Side effects | X group (n = 55) | C group (n = 59) | ||||||
| I | II | III | IV | I | II | III | IV | |
| Leukopenia | 21 | 8 | 5 | 0 | 20 | 8 | 4 | 0 |
| Thrombocytopenia | 10 | 5 | 1 | 0 | 13 | 4 | 2 | 0 |
| Nausea | 15 | 19 | 10 | 2 | 16 | 20 | 11 | 2 |
| Vomiting | 11 | 11 | 4 | 1 | 14 | 12 | 3 | 2 |
| Diarrhea | 7 | 9 | 3 | 0 | 5 | 6 | 2 | 0 |
| HFS | 32 | 2 | 1 | 0 | 8 | 2 | 0 | 0 |
| Neurotoxicity | 12 | 11 | 0 | 0 | 14 | 12 | 1 | 0 |
- Citation: Fan L, Liu WC, Zhang YJ, Ren J, Pan BR, Liu DH, Chen Y, Yu ZC. Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies. World J Gastroenterol 2005; 11(28): 4300-4304
- URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i28.4300